[FG] Lyrer Philippe

Zietz, Annaelle et al. (2024) ‘Enhancement of STroke REhabilitation with Levodopa (ESTREL): Rationale and design of a randomized placebo-controlled, double blind superiority trial’, European Stroke Journal, 9(4), pp. 1093–1102. Available at: https://doi.org/10.1177/23969873241255867.

Maarse, Moniek et al. (2024) ‘Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation’, JAMA Neurology, 81(11), p. 1150. Available at: https://doi.org/10.1001/jamaneurol.2024.2882.

Avramiotis, Nikolaos S et al. (2024) ‘Antithrombotic drugs for carotid artery dissection: Updated systematic review’, European Stroke Journal [Preprint]. Available at: https://doi.org/10.1177/23969873241292278.

Fandler-Höfler, Simon et al. (2024) ‘Sex Differences in Frequency, Severity, and Distribution of Cerebral Microbleeds’, JAMA Network Open, 7(10), p. e2439571. Available at: https://doi.org/10.1001/jamanetworkopen.2024.39571.

Brunner, E. et al. (2024) ‘Atherosclerosis in patients with cervical artery dissection’, European Stroke Journal [Preprint]. Available at: https://doi.org/10.1177/23969873241274547.

Brunner, Eveline et al. (2024) ‘Atherosclerosis in patients with cervical artery dissection’, European Stroke Journal [Preprint]. Available at: https://doi.org/10.1177/23969873241274547.

Kaufmann, Josefin E. et al. (2024) ‘Antithrombotic Treatment for Cervical Artery Dissection’, JAMA Neurology, 81(6), p. 630. Available at: https://doi.org/10.1001/jamaneurol.2024.1141.

Siepen, Bernhard M et al. (2024) ‘Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors — Individual patient data analysis of ANNEXA-4 and TICH-NOAC’, International Journal of Stroke, 19(5), pp. 506–514. Available at: https://doi.org/10.1177/17474930241230209.

Kaufmann, Josefin E. et al. (2024) ‘Toward Individual Treatment in Cervical Artery Dissection: Subgroup Analysis of the TREAT‐CAD Randomized Trial’, Annals of Neurology, 95(5), pp. 886–897. Available at: https://doi.org/10.1002/ana.26886.

Rekk, Katharina et al. (2024) ‘Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke—A case control study’, PLOS ONE, 19(4), p. e0301421. Available at: https://doi.org/10.1371/journal.pone.0301421.

Marvardi, M. et al. (2024) ‘Statin Therapy in Ischemic Stroke Patients with Atrial Fibrillation: Efficacy and Safety Outcomes’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.04.19.24306111.

Lyrer, Philippe et al. (2024) ‘Stroke Units und Stroke Centers in der Schweiz’, Swiss Medical Forum ‒ Schweizerisches Medizin-Forum [Preprint]. Available at: https://doi.org/10.4414/smf.2024.1343858063.

Mazighi, Mikaël et al. (2024) ‘Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial’, The Lancet Neurology, 23(2), pp. 157–167. Available at: https://doi.org/10.1016/s1474-4422(23)00427-1.

Fandler-Höfler, Simon et al. (2024) ‘Sex Differences in Frequency, Severity, and Distribution of Cerebral Microbleeds’, JAMA network open, 7, p. e2439571. Available at: https://doi.org/10.1001/jamanetworkopen.2024.39571.

Rekk, Katharina et al. (2024) ‘Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke-A case control study’, PLoS ONE, 19. Available at: https://doi.org/10.1371/journal.pone.0301421.

Rigutini, Andrea Galeazzo et al. (2024) ‘The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study’, Clinical and Applied Thrombosis/Hemostasis, 30. Available at: https://doi.org/10.1177/10760296241240746.

Dietrich, Fine et al. (2023) ‘Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study)’, Journal of Neurology [Preprint]. Available at: https://doi.org/10.1007/s00415-023-12035-z.

Ding, Wern Yew et al. (2023) ‘Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry’, Journal of Thrombosis and Thrombolysis, 57(1), pp. 39–49. Available at: https://doi.org/10.1007/s11239-023-02866-y.

De Marchis, Gian Marco et al. (2023) ‘Biomarker, Imaging, and Clinical Factors Associated with Overt and Covert Stroke in Patients with Atrial Fibrillation’, Stroke, 54, pp. 2542–2551. Available at: https://doi.org/10.1161/strokeaha.123.043302.

Dittrich, Tolga D et al. (2023) ‘Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients’, International Journal of Stroke, 18, pp. 697–703. Available at: https://doi.org/10.1177/17474930221140793.

Dittrich, Tolga D. et al. (2023) ‘Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort Study’, Stroke, 54, pp. 722–730. Available at: https://doi.org/10.1161/strokeaha.122.039793.

Seiffge DJ et al. (2022) ‘Cerebral Amyloid Angiopathy and the Risk of Hematoma Expansion.’, Annals of neurology, 92(6), pp. 921–930. Available at: https://doi.org/10.1002/ana.26481.

Sztajzel RF et al. (2022) ‘Carotid plaque surface echogenicity predicts cerebrovascular events: An Echographic Multicentric Swiss Study.’, Journal of neuroimaging : official journal of the American Society of Neuroimaging, 32(6), pp. 1142–1152. Available at: https://doi.org/10.1111/jon.13026.

Altersberger VL et al. (2022) ‘Thrombolysis in stroke patients with elevated inflammatory markers.’, Journal of neurology, 269(10), pp. 5405–5419. Available at: https://doi.org/10.1007/s00415-022-11173-0.

Paciaroni M et al. (2022) ‘Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study.’, Stroke, 53(8), pp. 2620–2627. Available at: https://doi.org/10.1161/strokeaha.121.038239.

Del Brutto VJ et al. (2022) ‘Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.’, Journal of the American Heart Association, 11(11), p. e023545. Available at: https://doi.org/10.1161/jaha.121.023545.

Polymeris AA et al. (2022) ‘Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation.’, Journal of neurology, neurosurgery, and psychiatry, 93(6), pp. 588–598. Available at: https://doi.org/10.1136/jnnp-2021-328391.

Goeldlin MB et al. (2022) ‘Etiology, 3-Month Functional Outcome and Recurrent Events in Non-Traumatic Intracerebral Hemorrhage.’, Journal of stroke, 24(2), pp. 266–277. Available at: https://doi.org/10.5853/jos.2021.01823.

Wagner B et al. (2022) ‘Endovascular Treatment for Acute Ischemic Stroke With or Without General Anesthesia: A Matched Comparison.’, Stroke, 53(5), pp. 1520–1529. Available at: https://doi.org/10.1161/strokeaha.121.034934.

Law ZK et al. (2022) ‘Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial.’, Stroke, 53(4), pp. 1141–1148. Available at: https://doi.org/10.1161/strokeaha.121.035191.

De Marchis GM et al. (2022) ‘Association of the COVID-19 outbreak with acute stroke care in Switzerland.’, European journal of neurology, 29(3), pp. 724–731. Available at: https://doi.org/10.1111/ene.15209.

De Marchis GM et al. (2022) ‘Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis.’, Journal of neurology, neurosurgery, and psychiatry, 93(2), pp. 119–125. Available at: https://doi.org/10.1136/jnnp-2021-327236.

Potasso L et al. (2022) ‘Impact of Sodium Levels on Functional Outcomes in Patients With Stroke - A Swiss Stroke Registry Analysis.’, The Journal of clinical endocrinology and metabolism, 107(2), pp. e672–e680. Available at: https://doi.org/10.1210/clinem/dgab650.

Schaub F et al. (2022) ‘Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage.’, Journal of the American Heart Association, 11(1), p. e023345. Available at: https://doi.org/10.1161/jaha.121.023345.

Alexandros A Polymeris (2022) Stroke, atrial fibrillation, and the management of oral anticoagulation. Unibas. Available at: https://doi.org/10.5451/unibas-ep88284.

Altersberger, Valerian L. et al. (2022) ‘Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration’, Stroke, 53, pp. 3557–3563. Available at: https://doi.org/10.1161/strokeaha.122.039426.

Beier L et al. (2022) ‘Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.’, PloS one, 17(10), p. e0274237. Available at: https://doi.org/10.1371/journal.pone.0274237.

Dietrich F et al. (2022) ‘Impact of the COVID-19 lockdown on the adherence of stroke patients to direct oral anticoagulants: a secondary analysis from the MAAESTRO study.’, Journal of neurology, 269(1), pp. 19–25. Available at: https://doi.org/10.1007/s00415-021-10631-5.

Kimura, Shunsuke et al. (2022) ‘Practical ‘1-2-3-4-Day’ Rule for Starting Direct Oral Anticoagulants after Ischemic Stroke with Atrial Fibrillation: Combined Hospital-Based Cohort Study’, Stroke, 53, pp. 1540–1549. Available at: https://doi.org/10.1161/strokeaha.121.036695.

Nowak, Bartosch et al. (2022) ‘Occurrence of No-Harm Incidents and Adverse Events in Hospitalized Patients with Ischemic Stroke or TIA: A Cohort Study Using Trigger Tool Methodology’, International Journal of Environmental Research and Public Health, 19(5), p. 2796. Available at: https://doi.org/10.3390/ijerph19052796.

Polymeris AA et al. (2022) ‘Renal Function and Body Mass Index Contribute to Serum Neurofilament Light Chain Levels in Elderly Patients With Atrial Fibrillation.’, Frontiers in neuroscience, 16, p. 819010. Available at: https://doi.org/10.3389/fnins.2022.819010.

Bahit MC et al. (2021) ‘Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.’, Circulation, 144(22), pp. 1738–1746. Available at: https://doi.org/10.1161/circulationaha.121.055176.

van der Wall SJ et al. (2021) ‘Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study.’, European journal of internal medicine, 91, pp. 75–80. Available at: https://doi.org/10.1016/j.ejim.2021.05.020.

Nordanstig A et al. (2021) ‘EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients (EVA-TRISP) registry: basis and methodology of a pan-European prospective ischaemic stroke revascularisation treatment registry.’, BMJ open, 11(8), p. e042211. Available at: https://doi.org/10.1136/bmjopen-2020-042211.

Göldlin M et al. (2021) ‘[Intracerebral haemorrhage - acute event and chronic disease].’, Therapeutische Umschau. Revue therapeutique, 78(6), pp. 320–327. Available at: https://doi.org/10.1024/0040-5930/a001276.

Tsagkas C et al. (2021) ‘Syndrome of inappropriate antidiuretic hormone secretion and hypothalamic hypocortisolism in neuromyelitis optica.’, Lancet (London, England), 397(10290), p. 2194. Available at: https://doi.org/10.1016/s0140-6736(21)00986-7.

Goeldlin, M. et al. (2021) ‘Abstract P407: Etiology And Outcomes Of Non-traumatic Intracerebral Hemorrhage - Data From The Swiss Stroke Registry’, Stroke, 52(Suppl_1). Available at: https://doi.org/10.1161/str.52.suppl_1.p407.

Albert V et al. (2021) ‘Insights Into Direct Oral Anticoagulant Therapy Implementation of Stroke Survivors with Atrial Fibrillation in an Ambulatory Setting.’, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 30(2), p. 105530. Available at: https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105530.

Albert, Valerie et al. (2021) ‘Insights into direct oral anticoagulant therapy implementation of stroke survivors with atrial fibrillation in an ambulatory setting’, J Stroke Cerebrovas Dis, 30(2), p. 105530. Available at: https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105530.

Best, Jonathan G et al. (2021) ‘Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies’, The Lancet Neurology, 20, pp. 294–303. Available at: https://doi.org/10.1016/s1474-4422(21)00024-7.

Dietrich, Fine et al. (2021) ‘Impact of the COVID-19 lockdown on the adherence of stroke patients to direct oral anticoagulants: a secondary analysis from the MAAESTRO study’, J Neurol, pp. 1–7. Available at: https://doi.org/10.1007/s00415-021-10631-5.

Dittrich, Tolga, Polymeris, Alexandros and De Marchis, Gian Marco (2021) ‘Challenges of treatment adherence with direct oral anticoagulants in pandemic’, Current opinion in neurology, 34(1), pp. 38–44. Available at: https://doi.org/10.1097/wco.0000000000000888.

Engelter, Stefan T et al. (2021) ‘Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.’, The Lancet. Neurology, 20(5), pp. 341–350. Available at: https://doi.org/10.1016/s1474-4422(21)00044-2.

Engelter ST, Lyrer P and Traenka C (2021) ‘Cervical and intracranial artery dissections.’, Therapeutic advances in neurological disorders, 14, p. 17562864211037238. Available at: https://doi.org/10.1177/17562864211037238.

Engelter ST et al. (2021) ‘Cervical Artery Dissection and Sports.’, Frontiers in neurology, 12, p. 663830. Available at: https://doi.org/10.3389/fneur.2021.663830.

Fladt, Joachim et al. (2021) ‘Stroke Unit-/ Stroke Center Care’, Therapeutische Umschau, 78, pp. 328–338. Available at: https://doi.org/10.1024/0040-5930/a001277.

Meya, Louisa et al. (2021) ‘Oral Anticoagulants in Atrial Fibrillation Patients With Recent Stroke Who Are Dependent on the Daily Help of Others.’, Stroke, p. STROKEAHA120033862. Available at: https://doi.org/10.1161/strokeaha.120.033862.

Müller MD et al. (2021) ‘Carotid Artery Stenting Versus Endarterectomy for Treatment of Carotid Artery Stenosis.’, Stroke, 52(1), pp. e3–e5. Available at: https://doi.org/10.1161/strokeaha.120.030521.

Tsagkas, Charidimos et al. (2021) ‘Acute Polyradiculomyelitis With Spinal Cord Gray Matter Lesions: A Report of Two Cases’, Frontiers in Neurology, 12, p. 721669. Available at: https://doi.org/10.3389/fneur.2021.721669.

Kronlage C et al. (2020) ‘Muscle stiffness, gait instability, and liver cirrhosis in Wilson’s disease.’, Lancet (London, England), 396(10256), p. 990. Available at: https://doi.org/10.1016/s0140-6736(20)31963-2.

Peters N et al. (2020) ‘Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease.’, Journal of stroke, 22(3), pp. 369–376. Available at: https://doi.org/10.5853/jos.2019.02845.

Traenka C et al. (2020) ‘Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial.’, European stroke journal, 5(3), pp. 309–319. Available at: https://doi.org/10.1177/2396987320921151.

Tsivgoulis G et al. (2020) ‘Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation.’, European journal of neurology, 27(8), pp. 1612–1617. Available at: https://doi.org/10.1111/ene.14280.

Diener HC et al. (2020) ‘Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.’, Stroke, 51(6), pp. 1758–1765. Available at: https://doi.org/10.1161/strokeaha.119.028643.

Müller MD et al. (2020) ‘Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis.’, The Cochrane database of systematic reviews, 2(2), p. CD000515. Available at: https://doi.org/10.1002/14651858.cd000515.pub5.

Seiffge DJ et al. (2020) ‘Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation.’, Annals of neurology, 87(5), pp. 677–87. Available at: https://doi.org/10.1002/ana.25700.

Traenka C et al. (2020) ‘Artery occlusion independently predicts unfavorable outcome in cervical artery dissection.’, Neurology, 94(2), pp. e170–e180. Available at: https://doi.org/10.1212/wnl.0000000000008654.

Cappellari, Manuel et al. (2020) ‘A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke’, European stroke journal, 5(4), pp. 384–393. Available at: https://doi.org/10.1177/2396987320945840.

Polymeris, Alexandros A. et al. (2020) ‘Serum neurofilament light in atrial fibrillation: clinical, neuroimaging and cognitive correlates’, Brain communications, 2(2), p. fcaa166. Available at: https://doi.org/10.1093/braincomms/fcaa166.

Traenka C et al. (2020) ‘Clinical Usefulness of Serial Duplex Ultrasound in Cervical Artery Dissection Patients.’, Cerebrovascular diseases (Basel, Switzerland), 49(2), pp. 206–215. Available at: https://doi.org/10.1159/000507485.

Westphal, Laura P. et al. (2020) ‘Association of prestroke metformin use, stroke severity, and thrombolysis outcome’, Neurology, 95(4), pp. e362–e373. Available at: https://doi.org/10.1212/wnl.0000000000009951.

Seiffge DJ et al. (2019) ‘Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use.’, Journal of neurology, 266(12), pp. 3126–3135. Available at: https://doi.org/10.1007/s00415-019-09536-1.

Traenka C et al. (2019) ‘Rare genetic variants in patients with cervical artery dissection.’, European stroke journal, 4(4), pp. 355–362. Available at: https://doi.org/10.1177/2396987319861869.

Müller MD et al. (2019) ‘Stent Design, Restenosis and Recurrent Stroke After Carotid Artery Stenting in the International Carotid Stenting Study.’, Stroke, 50(11), pp. 3013–3020. Available at: https://doi.org/10.1161/strokeaha.118.024076.

Polymeris AA et al. (2019) ‘Intravenous thrombolysis for suspected ischemic stroke with seizure at onset.’, Annals of neurology, 86(5), pp. 770–779. Available at: https://doi.org/10.1002/ana.25582.

Paciaroni M et al. (2019) ‘Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.’, Stroke, 50(8), pp. 2168–2174. Available at: https://doi.org/10.1161/strokeaha.119.025350.

Seiffge DJ et al. (2019) ‘Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.’, Annals of neurology, 85(6), pp. 823–834. Available at: https://doi.org/10.1002/ana.25489.

Diener HC et al. (2019) ‘Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.’, The New England journal of medicine, 380(20), pp. 1906–1917. Available at: https://doi.org/10.1056/nejmoa1813959.

Galovic M et al. (2019) ‘Development and Validation of a Prognostic Model of Swallowing Recovery and Enteral Tube Feeding After Ischemic Stroke.’, JAMA neurology, 76(5), pp. 561–570. Available at: https://doi.org/10.1001/jamaneurol.2018.4858.

Polymeris AA et al. (2019) ‘Transient focal neurologic deficits upon hematopoietic stem cell transplantation: just a coincidence?’, 119(1). Available at: https://doi.org/10.1007/s13760-017-0846-z.

Pfeiffer D et al. (2019) ‘Genetic Imbalance Is Associated With Functional Outcome After Ischemic Stroke.’, Stroke, 50(2), pp. 298–304. Available at: https://doi.org/10.1161/strokeaha.118.021856.

De Marchis, Gian Marco et al. (2019) ‘A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score’, Neurology, 92(13), pp. e1517–e1525. Available at: https://doi.org/10.1212/wnl.0000000000007177.

Fladt, Joachim et al. (2019) ‘Fast-Track versus Long-Term Hospitalizations for Patients with Non-Disabling Acute Ischemic Stroke’, European journal of neurology. 23.07.2018, 26(1), pp. 51–e4. Available at: https://doi.org/10.1111/ene.13761.

Fladt, Joachim et al. (2019) ‘Reasons for prehospital delay in acute ischemic stroke’, Journal of the American Heart Association, 8(20), p. e013101. Available at: https://doi.org/10.1161/jaha.119.013101.

Müller MD et al. (2019) ‘Silent Intracerebral Hemorrhage in Patients Randomized to Stenting or Endarterectomy for Symptomatic Carotid Stenosis.’, Journal of stroke, 21(1), pp. 116–119. Available at: https://doi.org/10.5853/jos.2018.02838.

Ritz MF et al. (2019) ‘Combined Transcriptomic and Proteomic Analyses of Cerebral Frontal Lobe Tissue Identified RNA Metabolism Dysregulation as One Potential Pathogenic Mechanism in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL).’, Current neurovascular research, 16(5), pp. 481–493. Available at: https://doi.org/10.2174/1567202616666191023111059.

Stefan T. Engelter et al. (2019) ‘Pharmakologische Unterstützung der Neurorehabilitation nach Schlaganfall mit Levodopa’, Psychiatrie + Neurologie, 20(4), pp. 14–17.

Waje-Andreassen U et al. (2018) ‘European Stroke Organisation certification of stroke units and stroke centres.’, European stroke journal, 3(3), pp. 220–226. Available at: https://doi.org/10.1177/2396987318778971.

Compter A et al. (2018) ‘Determinants and outcome of multiple and early recurrent cervical artery dissections.’, Neurology, 91(8), pp. e769–e780. Available at: https://doi.org/10.1212/wnl.0000000000006037.

Bonati LH et al. (2018) ‘Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial.’, The Lancet. Neurology. 01.06.2018, 17(7), pp. 587–596. Available at: https://doi.org/10.1016/s1474-4422(18)30195-9.

Duering M et al. (2018) ‘Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden.’, Journal of stroke. 31.05.2018, 20(2), pp. 228–238. Available at: https://doi.org/10.5853/jos.2017.02565.

Kellert L et al. (2018) ‘University education and cervical artery dissection.’, Journal of neurology, 265(5), pp. 1065–1070. Available at: https://doi.org/10.1007/s00415-018-8798-7.

Kurmann R et al. (2018) ‘Impact of Smoking on Clinical Outcome and Recanalization After Intravenous Thrombolysis for Stroke: Multicenter Cohort Study.’, Stroke, 49(5), pp. 1170–1175. Available at: https://doi.org/10.1161/strokeaha.117.017976.

Seiffge DJ et al. (2018) ‘Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.’, Annals of neurology, 83(3), pp. 451–459. Available at: https://doi.org/10.1002/ana.25165.

Traenka C et al. (2018) ‘Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke - Results from the SWISS registry.’, European stroke journal, 3(1), pp. 47–56. Available at: https://doi.org/10.1177/2396987317748545.

Gensicke H et al. (2018) ‘Intravenous thrombolysis and platelet count.’, Neurology, 90(8), pp. e690–e697. Available at: https://doi.org/10.1212/wnl.0000000000004982.

De Marchis, Gian Marco et al. (2018) ‘Serum neurofilament light chain in patients with acute cerebrovascular events’, European Journal of Neurology, 25(3), pp. 562–568. Available at: https://doi.org/10.1111/ene.13554.

Erdur H et al. (2018) ‘A Score for Risk of Thrombolysis-Associated Hemorrhage Including Pretreatment with Statins.’, Frontiers in neurology. 16.02.2018, 9, p. 74. Available at: https://doi.org/10.3389/fneur.2018.00074.

Polymeris, Alexandros A. et al. (2018) ‘Protocol for MAAESTRO: Electronic Monitoring and Improvement of Adherence to Direct Oral Anticoagulant Treatment-A Randomized Crossover Study of an Educational and Reminder-Based Intervention in Ischemic Stroke Patients Under Polypharmacy’, Frontiers in Neurology, 9, p. 1134. Available at: https://doi.org/10.3389/fneur.2018.01134.

Seiffge D.J. et al. (2018) ‘Management of patients with stroke treated with direct oral anticoagulants’, Journal of Neurology, 265, pp. 3022–3033. Available at: https://doi.org/10.1007/s00415-018-9061-y.